Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy

Neuroscience Letters

Volumn 411, Issue 1, 2007, Pages 11-16

  Deshpande, Laxmikant S ^a   Sombati, Sompong ^a   Blair, Robert E ^a   Carter, Dawn S ^b   Martin, Billy R ^b   DeLorenzo, Robert J ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cannabinoid; CB1 receptor; Endocannabinoid tone; Epilepsy; Status epilepticus

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT;

ANIMAL CELL; ARTICLE; ELECTROPHYSIOLOGY; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTIC STATE; HIPPOCAMPUS; NERVE CELL CULTURE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; EPILEPSY; HIPPOCAMPUS; MORPHOLINES; NAPHTHALENES; NEURONS; PATCH-CLAMP TECHNIQUES; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SYNAPTIC TRANSMISSION;

EID: 33750993072     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.09.046     Document Type: Article

References (20)

1. Adams I.B., and Martin B.R. Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (1996) 1585-1614
2. Blair R.E., Deshpande L.S., Sombati S., Falenski K.W., Martin B.R., and Delorenzo R.J. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J. Pharmacol. Exp. Ther. 317 (2006) 1072-1078
3. DeLorenzo R.J., Hauser W.A., Towne A.R., Boggs J.G., Pellock J.M., Penberthy L., Garnett L., Fortner C.A., and Ko D. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46 (1996) 1029-1035
4. Delorenzo R.J., Sun D.A., and Deshpande L.S. Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol. Ther. 105 (2005) 229-266
5. W.A Hauser, D.C. Hesdorffer, Epilepsy: Frequency, Causes and Consequences, Demos, 1990.
6. Karler R., Cely W., and Turkanis S.A. Anticonvulsant properties of delta 9-tetrahydrocannabinol and other cannabinoids. Life Sci. 15 (1974) 931-947
7. Kreitzer A.C., and Regehr W.G. Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J. Neurosci. 21 (2001) RC174
8. Lan R., Liu Q., Fan P., Lin S., Fernando S.R., McCallion D., Pertwee R., and Makriyannis A. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem. 42 (1999) 769-776
9. Lothman E.W., Bertram III E.H., and Stringer J.L. Functional anatomy of hippocampal seizures. Prog. Neurobiol. 37 (1991) 1-82
10. Lutz B. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem. Pharmacol. 68 (2004) 1691-1698
11. Mackie K. Cannabinod receptors as therapeutic targets. Annal. Rev. Pharmacol. Toxicol. 46 (2006) 101-122
12. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutierrez S.O., van der Stelt M., Lopez-Rodriguez M.L., Casanova E., Schutz G., Zieglgansberger W., Di Marzo V., Behl C., and Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
13. Ohno-Shosaku T., Maejima T., and Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29 (2001) 729-738
14. Ohno-Shosaku T., Tsubokawa H., Mizushima I., Yoneda N., Zimmer A., and Kano M. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J. Neurosci. 22 (2002) 3864-3872
15. Schlicker E., and Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22 (2001) 565-572
16. Sombati S., and DeLorenzo R.J. Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture. J. Neurophysiol. 73 (1995) 1706-1711
17. Towne A.R., Pellock J.M., Ko D., and DeLorenzo R.J. Determinants of mortality in status epilepticus. Epilepsia 35 (1994) 27-34
18. Wallace M.J., Blair R.E., Falenski K.W., Martin B.R., and DeLorenzo R.J. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther. 307 (2003) 129-137
19. Wallace M.J., Martin B.R., and DeLorenzo R.J. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur. J. Pharmacol. 452 (2002) 295-301
20. Wallace M.J., Wiley J.L., Martin B.R., and DeLorenzo R.J. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur. J. Pharmacol. 428 (2001) 51-57